阿拉吉尔综合征
JAG1
胆管上皮细胞
赫斯1
体内
Notch信号通路
肝细胞
细胞生物学
生物
肝内胆管
胆汁淤积
类有机物
胆管
癌症研究
体外
内科学
医学
信号转导
内分泌学
遗传学
作者
Afshan Iqbal,Noémi Van Hul,Lenka Belicová,Agustín A. Corbat,Simona Hankeová,Emma Andersson
摘要
Abstract Background & Aims Alagille syndrome (ALGS) manifests with peripheral intrahepatic bile duct (IHBD) paucity, which can spontaneously resolve. In a model for ALGS, Jag1 Ndr/Ndr mice, this occurs with distinct architectural mechanisms in hilar and peripheral IHBDs. Here, we investigated region‐specific IHBD characteristics and addressed whether IGF1, a cholangiocyte mitogen that is downregulated in ALGS and in Jag1 Ndr/Ndr mice, can improve biliary outcomes. Methods Intrahepatic cholangiocyte organoids (ICOs) were derived from hilar and peripheral adult Jag1 +/+ and Jag1 Ndr/Ndr livers (hICOs and pICOs, respectively). ICOs were grown in Matrigel or microwell arrays, and characterized using bulk RNA sequencing, immunofluorescence, and high throughput analyses of nuclear sizes. ICOs were treated with IGF1, followed by analyses of growth, proliferation, and death. CellProfiler and Python scripts were custom written for image analyses. Key results were validated in vivo by immunostaining. Results Cell growth assays and transcriptomics demonstrated that Jag1 Ndr/Ndr ICOs were less proliferative than Jag1 +/+ ICOs. IGF1 specifically rescued survival and growth of Jag1 Ndr/Ndr pICOs. Jag1 Ndr/Ndr hICOs were the least proliferative, with lower Notch signalling and an enrichment of hepatocyte signatures and IGF uptake/transport pathways. In vitro ( Jag1 Ndr/Ndr hICOs) and in vivo ( Jag1 Ndr/Ndr hilar portal tracts) analyses revealed ectopic HNF4a + hepatocytes. Conclusions Hilar and peripheral Jag1 Ndr/Ndr ICOs exhibit differences in Notch signalling status, proliferation, and cholangiocyte commitment which may result in cholangiocyte‐to‐hepatocyte transdifferentiation. While Jag1 Ndr/Ndr pICOs can be rescued by IGF1, hICOs are unresponsive, perhaps due to their hepatocyte‐like state and/or expression of IGF transport components. IGF1 represents a potential therapeutic for peripheral bile ducts.
科研通智能强力驱动
Strongly Powered by AbleSci AI